SIC 2836 – Biological Products, Except Diagnostic Substances (Biotech)
| Valuation | |
|---|---|
| Market Cap ($M) | 207.10 |
| Enterprise Value ($M) | 102.44 |
| Book Value ($M) | 302.71 |
| Book Value / Share | 7.02 |
| Price / Book | 0.68 |
| NCAV ($M) | 288.89 |
| NCAV / Share | 6.70 |
| Price / NCAV | 0.72 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -0.35 |
| Return on Assets (ROA) | -1.20 |
| Return on Equity (ROE) | -1.61 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 10.50 |
| Current Ratio | 10.50 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 325.37 |
| Assets | 339.20 |
| Liabilities | 36.49 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.00 |
| Operating Income | 0.00 |
| Net Income | 0.00 |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | 0.00 |
| Cash from Investing | 0.00 |
| Cash from Financing | 0.00 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G | Westlake BioPartners Fund I, L.P. | 10.50 | ||
| 13G | Jpmorgan Chase & Co | 5.50 | ||
| 13D | Vida Ventures, LLC | 11.10 | ||
| 13G | Northpond Ventures III, LP | 7.60 | ||
| 13G | Gilead Sciences Inc | 9.60 | ||
| 13G | Bain Capital Life Sciences Opportunities III, LP | 7.40 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 54,858 | 271,060 | 20.24 | |
| 56,719 | 224,667 | 25.25 | |
| 22,323 | 99,707 | 22.39 | |
| 37,092 | 245,191 | 15.13 | |
| 33,064 | 133,124 | 24.84 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| KRON – Kronos Bio, Inc. | KRYS – Krystal Biotech, Inc. |
| KURA – Kura Oncology, Inc. | LVTX – LAVA Therapeutics N.V. |
| LXRX – Lexicon Pharmaceuticals, Inc. |
Financial data and stock pages provided by
Fintel.io